These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 32800939)
1. Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing. Xu P; Li J; Meda A; Osei-Yeboah F; Peterson ML; Repka M; Zhan X Int J Pharm; 2020 Oct; 588():119760. PubMed ID: 32800939 [TBL] [Abstract][Full Text] [Related]
2. Strategies and mechanisms to improve the printability of pharmaceutical polymers Eudragit® EPO and Soluplus®. Yang Y; Wang H; Xu X; Yang G Int J Pharm; 2021 Apr; 599():120410. PubMed ID: 33639229 [TBL] [Abstract][Full Text] [Related]
3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
4. Development of a Simple Mechanical Screening Method for Predicting the Feedability of a Pharmaceutical FDM 3D Printing Filament. Nasereddin JM; Wellner N; Alhijjaj M; Belton P; Qi S Pharm Res; 2018 May; 35(8):151. PubMed ID: 29855818 [TBL] [Abstract][Full Text] [Related]
6. Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers. Tabriz AG; Scoutaris N; Gong Y; Hui HW; Kumar S; Douroumis D Int J Pharm; 2021 Jul; 604():120755. PubMed ID: 34052338 [TBL] [Abstract][Full Text] [Related]
7. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Alhijjaj M; Belton P; Qi S Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210 [TBL] [Abstract][Full Text] [Related]
8. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation. Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954 [TBL] [Abstract][Full Text] [Related]
9. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
10. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535 [TBL] [Abstract][Full Text] [Related]
11. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Korte C; Quodbach J Pharm Dev Technol; 2018 Dec; 23(10):1117-1127. PubMed ID: 29368974 [TBL] [Abstract][Full Text] [Related]
12. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing. Gültekin HE; Tort S; Acartürk F Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313 [TBL] [Abstract][Full Text] [Related]
13. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
14. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
15. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
16. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance. Bandari S; Nyavanandi D; Dumpa N; Repka MA Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
18. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery. Tan DK; Maniruzzaman M; Nokhodchi A Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002 [TBL] [Abstract][Full Text] [Related]
19. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines. Elbadawi M; Muñiz Castro B; Gavins FKH; Ong JJ; Gaisford S; Pérez G; Basit AW; Cabalar P; Goyanes A Int J Pharm; 2020 Nov; 590():119837. PubMed ID: 32961295 [TBL] [Abstract][Full Text] [Related]
20. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]